Home
Our Focus
Overview
Literature & Publications
Pipeline
Overview
Acute Ischemic Stroke
Cardio-Renal Disease
Clinical Trials
Overview
Acute Ischemic Stroke
ReMEDy2
Overview
About ReMEDy2
Stroke Disease
For Physicians
Trial Locations
About DiaMedica
Overview
Leadership
Careers
Contact
Investors Relations
Overview
Press Releases
Events & Presentations
Stock Data
Analyst Coverage
Financial Reports & SEC Filings
Governance
Resources
SEC Filings
Investors Relations
Investors Relations
Overview
Press Releases
Events & Presentations
Stock Data
Nasdaq Quote
Charts
Historical Data
Analyst Coverage
Financial Reports & SEC Filings
SEC Filings
Annual Reports
Tax Information (PFIC)
Governance
Board of Directors
Board Committees
Governance Documents
Resources
Investor Contact
FAQ
Share Consolidation Instructions
Email Alerts
Financial Reports & SEC Filings
SEC Filings
Annual Reports
Tax Information (PFIC)
Filing Type:
View All
10-K
10-K/A
10-Q
20FR12B
20FR12B/A
3
4
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
REGDEX
RW
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2014
2007
Date
Form
Description
PDF
XBRL
Pages
05/04/22
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-31.1
EX-31.2
EX-32.1
EX-32.2
28
05/04/22
8-K
Current report filing
Documents
EX-99.1
10
04/05/22
DEFA14A
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
3
04/05/22
DEF 14A
Definitive proxy statements
94
03/14/22
S-8
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Documents
EX-5.1
EX-23.1
EX-FILING FEES
11
03/14/22
10-K
Annual report pursuant to Section 13 and 15(d)
Documents
EX-10.2
EX-10.5
EX-10.6
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
171
03/14/22
8-K
Current report filing
Documents
EX-99.1
10
02/15/22
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
3
02/11/22
8-K
Current report filing
3
02/11/22
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
6
Previous
1…
7
8
9
10
11
12
13
14
15
16
…31
Next
Email Alerts
Contacts
RSS News Feed